| | | ORNITHINE ASPARTATE (L-ORNITHINE L-ASPARTATE)
CAS:3230-94-2
Trade Name: (2S)-2-aminobutanedioic acid;(2S)-2,5-diaminopentanoic acid
Formula: C5H12N2O2.C4H7NO4
APS3230942
265.26
Aspartic acid compd. with ornithine, Ornithine Aspartate (L-Ornithine L-Aspartate), Ormeta, L-Ornithine L-aspartate,L-Aspartic acid, compd. with L-ornithine (1:1), Orparan, Ruigan, Ornithine, L-, L-aspartate (1:1) (8CI), L-Ornithine, L-aspa OROTIC ACID
CAS:65-86-1
Trade Name: 2,4-Dioxo-1H-pyrimidine-6-carboxylic acid
Formula: C5H4N2O4
APS65861
156.10
2,6-Dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid, Orotyl, Vitamin B13, Whey factor, 6-Carboxyuracil, 2,4-Dioxo-1H-pyrimidine-6-carboxylic acid, Orotonin,4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, 6-Uracilcarboxylic OROTIC ACID-15N2 MONOHYDRATE
CAS:1346602-15-0
Trade Name: 2,4-dioxo-(2^{13}C,1,3-^{15}N_{2})1H-pyrimidine-6-carboxylic acid;hydrate
Formula: 13CC4H415N2O4-+H2O
ACM1346602150-1
177.09
1,2,3,6-Tetrahydro-2,6-dioxo-4-pyrimidine-2-13C-1,3-15N2-carboxylic acid monohydrate, Orotic acid-13C,15N2 monohydrate, Orotic acid-2-13C,1,3-15N2 monohydrate, 2,4-Dioxo-1H-pyrimidine-2-13C-1,3-15N2-6-carboxylic acid monohydrate, 2,4-Dihydr OROTIDINE
CAS:314-50-1
Trade Name: 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid
Formula: C10H12N2O8
APS314501
288.21
1,2,3,6-Tetrahydro-2,6-dioxo-3-+¦-D-ribofuranosyl-4-pyrimidinecarboxylic acid, Orotic acid riboside,4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-3-+¦-D-ribofuranosyl-, Orotidine (6CI,7CI,8CI), 6-Carboxyuridine OROXIN A
CAS:57396-78-8
Trade Name: 5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-
Formula: C21H20O10
ACM57396788
432.38
BAICALEIN 7-O-B-D-GLUCOPYRANOSIDE (BAICALIN);5,6-Dihydroxy-7-(+¦-D-glucopyranosyloxy)-2-phenyl-4H-1-benzopyran-4-one;5,6-Dihydroxy-7-(+¦-D-glucopyranosyloxy)flavone;5,6-Dihydroxyflavone-7-yl +¦-D-glucopyranoside;7-(+¦-D-Glucopyranosyloxy)-5,6-d OROXIN A
CAS:57396-78-8
Trade Name: 5,6-dihydroxy-2-phenyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-
Formula: C21H20O10
ACM57396788
432.38
BAICALEIN 7-O-B-D-GLUCOPYRANOSIDE (BAICALIN);5,6-Dihydroxy-7-(+¦-D-glucopyranosyloxy)-2-phenyl-4H-1-benzopyran-4-one;5,6-Dihydroxy-7-(+¦-D-glucopyranosyloxy)flavone;5,6-Dihydroxyflavone-7-yl +¦-D-glucopyranoside;7-(+¦-D-Glucopyranosyloxy)-5,6-d ORPHENADRINE IMPURITY E
CAS:21945-86-8
Trade Name: N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine
Formula: C18H23NO
APS21945868
269.38
Ethylamine, N,N-dimethyl-2-[(m-methyl-alpha-phenylbenzyl)oxy]- (7CI,8CI), N,N-Dimethyl-2-[phenyl(m-tolyl)methoxy]ethanamine, (RS)-N,N-Dimethyl-2-[(3-methylphenyl)phenylmethoxy]ethanamine, Orphenadrine impurity E (EP), Orphenadrine Related C ORPHENADRINE N-OXIDE
CAS:29215-00-7
Trade Name: N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine oxide
Formula: C18H23NO2
APS29215007
285.38
Orphenadrine N-oxide,Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, N-oxide, Ethylamine, N,N-dimethyl-2-[(o-methyl-+¦-phenylbenzyl)oxy]-, N-oxide (8CI), Orphenadrine N-Oxide ORTHO TERTIARY BUTYL CYCLOHEXANYL ACETATE HIGH CIS
CAS:20298-69-5
Formula: C12H22O2
ACM20298695
198.30188
2-(1,1-dimethylethyl)-,acetate,cis-cyclohexano;2-(1,1-dimethylethyl)-,acetate,cis-Cyclohexanol;VERDOX HC;ORTHO TERTIARY BUTYL CYCLOHEXANYL ACETATE HIGH CIS;cis-2-tert-butylcyclohexyl acetate;Cyclohexanol, 2-(1,1-dimethylethyl)-, 1-acetate, Ortho-N-valeric acid triethyl ester
CAS:919-29-9
Trade Name: 1,1,1-triethoxypentane
Formula: C11H24O3
ACM919299
204.308
Triethyl Orthovalerate, 1,1,1-Triethoxypentane, Orthovaleric Acid Triethyl Ester, EINECS 213-047-9, CID70195, T0977, I14-6732, 919-29-9 ORTHOBORIC ACID,COMPOUND WITH 1,3,5-TRIAZINE-2,4,6-TRIAMINE
CAS:53587-44-3
Formula: C18H22O10
ACM53587443
orthoboric acid, compound with 1,3,5-triazine-2,4,6-triamine;Boric acid (H3BO3), compd. with 1,3,5-triazine-2,4,6-triamine;1,3,5-Triazine-2,4,6-triamine/boric acid,(1:x) ORTHOCAINE
CAS:536-25-4
Trade Name: methyl 3-amino-4-hydroxybenzoate
Formula: C8H9NO3
APS536254
167.16
3-Amino-4-hydroxybenzoic acid methyl ester, Aminobenz, Orthocaine, Orthoderm, NSC 9813, Methyl m-amino-p-hydroxybenzoate,Benzoic acid, 3-amino-4-hydroxy-, methyl ester, Methyl 4-hydroxy-3-aminobenzoate, Orthoform New, Orthoform (6CI), 1-Hyd ORTHODICHLOROACETIC ACID TRIETHYL ESTER
CAS:54567-92-9
Trade Name: 2,2-dichloro-1,1,1-triethoxyethane
Formula: C8H16Cl2O3
ACM54567929
231.12
Triethyl Orthodichloroacetate, 1,1,1-Triethoxy-2,2-dichloroethane, Orthodichloroacetic Acid Triethyl Ester, O0274, 54567-92-9 Orthosiphol A
CAS:142741-25-1
Trade Name: [(2R,4R,4aS,4bS,5R,6S,7S,8aS,10R,10aR)-6,10-diacetyloxy-5-benzoyloxy-2-ethenyl-7,10a-dihydroxy-2,4b,
Formula: C38H44O11
ACM142741251
676.7 OSELTAMIVIR ACID
CAS:187227-45-8
Trade Name: (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid
Formula: C14H24N2O4
APS187227458
284.35
Ro 64-0802, GS 4071,1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4R,5S)-, (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, Oseltamivir acid, 1-Cyclohexene-1-carboxyl OSELTAMIVIR ACID HYDROCHLORIDE
CAS:1415963-60-8
Trade Name: (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid;hydrochloride
Formula: C14H24N2O4.ClH
APS1415963608
320.81
Oseltamivir acid hydrochloride, (3R,4R,5S)-4-Acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid hydrochloride,1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, hydrochloride (1:1), (3R,4R,5S)- OSELTAMIVIR IMPURITY C
CAS:187227-45-8
Trade Name: (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid
Formula: C14H24N2O4
APS187227458A
284.35
Ro 64-0802, Oseltamivir acid,1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4R,5S)-, 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, [3R-(3+¦,4+¦,5+¦)]-, (3R,4R,5S)-4-(Acetylamin OSELTAMIVIR-D3
CAS:1093851-61-6
Trade Name: ethyl (3R,4R,5S)-5-amino-3-pentan-3-yloxy-4-[(2,2,2-trideuterioacetyl)amino]cyclohexene-1-carboxylat
Formula: C162H3H25N2O4
APS1093851616
315.42
(3R,4R,5S)-4-(Acetamido-2,2,2-d3)-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid ethyl ester, [3R-(3+¦,4+¦,5+¦)]-4-[(Acetyl-d3)amino]-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester, Ethyl (3R,4R,5S)-4-[(acet OSELTAMIVIR-D3 ACID
CAS:1242184-43-5
Trade Name: (3R,4R,5S)-5-amino-3-pentan-3-yloxy-4-[(2,2,2-trideuterioacetyl)amino]cyclohexene-1-carboxylic acid
Formula: C142H3H21N2O4
APS1242184435
287.37
Oseltamivir acid D3 (N-Acetyl-D3), (3R,4R,5S)-4-[(Acetyl-d3)amino]-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, (3R,4R,5S)-4-(Acetamido-2,2,2-d3)-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid, Oseltamivir acid-d3 OSELTAMIVIR-D3 ACID
CAS:1242184-43-5
Trade Name: (3R,4R,5S)-5-amino-3-pentan-3-yloxy-4-[(2,2,2-trideuterioacetyl)amino]cyclohexene-1-carboxylic acid
Formula: C14D3H21N2O4
ACM1242184435
287.37
[3R-(3a,4+ƒ,5a)]-4-[(Acetyl-d3)amino]-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, (3R,4R,5S)-4-[(Acetyl-d3)amino]-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid, Oseltamivir acid-d3, Oseltamivir acid D3 (N-Acetyl- OseltamivirGlucoseAdduct2
Formula: C20H32N2O8
APB01964
428.48
N-((1R,3S,4R,5R,11R,12S,13S,14R)-12,13,14-trihydroxy-8-oxo-5-(pentan-3-yloxy)-9,15-dioxa-2-azatricyclo[9.3.1.13,7]hexadec-6-en-4-yl)acetamide OSMR Protein, Canine, Recombinant (His)
RHC-RP-1283
81.73 kDa (predicted). Due to glycosylation, the p
PLCA1, OSMRBMGC150626, OSMRB, OSMR +¦, OSMR beta, OSMR, IL-31R-+¦, IL-31R-beta, IL-31RB, IL-31R subunit +¦, IL-31R subunit beta OSMR Protein, Cynomolgus, Recombinant (His)
RHC-RP-1360
82.04 kDa (predicted). Due to glycosylation, the p
PLCA1, OSMRBMGC150626, OSMRB, OSMR +¦, OSMR beta, OSMR, IL-31R-+¦, IL-31R-beta, IL-31RB, IL-31R subunit +¦, IL-31R subunit beta Osteopontin Protein, Cynomolgus, Recombinant (His)
RHC-CGF-1745
33.16 kDa (predicted). Due to glycosylation, the p
Uropontin, SPP-1, SPP1, Osteopontin, OPN, Nephropontin, ETA-1, BSPI, BSP-1, Bone sialoprotein 1, BNSP Osteopontin Protein, Human, Recombinant (aa 17-300, His)
RHC-CGF-1786
34.8 kDa (predicted). Due to glycosylation, the pr
Uropontin, SPP-1, SPP1, Osteopontin, OPN, Nephropontin, ETA-1, BSPI, BSP-1, Bone sialoprotein 1, BNSP Osteopontin Protein, Mouse, Recombinant (His)
RHC-CGF-1683
31.8 kDa (predicted). Due to glycosylation, the pr
Uropontin, SPP-1, SPP1, Osteopontin, OPN, Nephropontin, ETA-1, BSPI, BSP-1, Bone sialoprotein 1, BNSP OSTEOSTATIN(1-5)(HUMAN,BOVINE,DOG,HORSE,MOUSE,RABBIT,RAT)
CAS:138949-73-2
Trade Name: (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-5-(diaminomethylideneam
Formula: C27H41N9O8
ACM138949732
619.67
HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT);HYPERCALCEMIA OF MALIGNANCY FACTOR (107-111) (HUMAN, RAT);HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 107-111;H-THR-ARG-SER-ALA-TRP-OH;THR-ARG-SER- OSTEOSTATIN(1-5)AMIDE(HUMAN,BOVINE,DOG,HORSE,MOUSE,RABBIT,RAT)
CAS:155918-12-0
Trade Name: (2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl
Formula: C27H42N10O7
ACM155918120
618.69
PTH-RELATED PROTEIN (107-111) AMIDE (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT);PTH-RELATED PROTEIN (107-111) AMIDE (HUMAN, RAT);PTH-RP (107-111) AMIDE (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT);PTH-RP (107-111) AMIDE (HUMAN, RAT); OTAVA-BB 1113782
CAS:71195-71-6
Trade Name: 5-(4-methylanilino)-5-oxopentanoic acid
Formula: C12H15NO3
ACM71195716
221.2524
5-[(4-methylphenyl)amino]-5-oxopentanoic acid, ST50445380, 4-p-Tolylcarbamoyl-butyric acid, Oprea1_826816, AC1MU007, SCHEMBL7825018, MolPort-002-347-798, YRPDUMZWXRBNJE-UHFFFAOYSA-N, STL281676, AKOS001605226, MCULE-1449473830, 5-(4-methylan OTOPHYLLOSIDE B
CAS:106758-54-7
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C49H78O16
BBC106758547
923.15
Wilfoside C3N OTOPHYLLOSIDE B
CAS:106758-54-7
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C49H78O16
ACM106758547
923.15
Wilfoside C3N OTOPHYLLOSIDE B 4'''-O-ALPHA-L-CYMAROPYRANOSIDE
CAS:171422-82-5
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C56H90O19
ACM171422825
1067.31 OTOPHYLLOSIDE B 4'''-O-BETA-D-CYMAROPYRANOSIDE
CAS:171422-85-8
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C56H90O19
ACM171422858
1067.31 OTOPHYLLOSIDE B 4'''-O-BETA-D-OLEANDROPYRANOSIDE
CAS:168001-54-5
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C56H90O19
ACM168001545
1067.31 OTOPHYLLOSIDE F
CAS:250217-73-3
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5R
Formula: C48H76O16
ACM250217733
909.11 OTOPHYLLOSIDE O
CAS:1326583-08-7
Trade Name: [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5R,6R)-5-[(2S,4S,5R,6R)-5-[(2
Formula: C56H84O20
ACM1326583087
1077.25 OU749
CAS:519170-13-9
Trade Name: N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]benzenesulfonamide
Formula: C16H15N3O3S2
ACM519170139
361.44
OU749, ST50617799, 519170-13-9, N-[5-(4-methoxybenzyl)-1,3,4-thiadiazol-2-yl]benzenesulfonamide, BAS 05023505, AC1M2VAT, SureCN3011618, MLS000856641, CTK8E8881, MolPort-001-624-718, HMS2679F21, STK099853, AKOS000650891, MCULE-4407055637, SM OX40/TNFRSF4 Protein (Primary Amine Labeling), Human, Recombinant (hFc), Biotinylated
RHC-CD-2337
46.8 kDa (predicted). Due to glycosylation, the pr
TNFRSF4, OX40L receptor, OX40 homologue, OX40, Ly-70, IMD16, CD134, ACT-135, TXGP1L OX40/TNFRSF4 Protein, Human, Recombinant (aa 29-216, His & Avi), Biotinylated
RHC-CD-1888
23.2 kDa (predicted). Due to glycosylation, the pr
TNFRSF4, OX40L receptor, OX40 homologue, OX40, Ly-70, IMD16, CD134, ACT-135, TXGP1L OX40/TNFRSF4 Protein, Human, Recombinant (His & Avi)
RHC-CD-2211
23.2 kDa (predicted). Due to glycosylation, the pr
TNFRSF4, OX40L receptor, OX40 homologue, OX40, Ly-70, IMD16, CD134, ACT-135, TXGP1L OX40/TNFRSF4 Protein, Mouse, Recombinant (hFc)
RHC-CD-2384
48.3 kDa (predicted); 60 kDa (reducing condition,
TXGP1L, Txgp1, tumor necrosis factor receptor superfamily, member 4, Ox40, Ly-70, CD134, ACT35 OX40/TNFRSF4 Protein, Mouse, Recombinant (His & Avi)
RHC-CD-1913
24.2 kDa (predicted). Due to glycosylation, the pr
TNFRSF4, OX40L receptor, OX40 homologue, OX40, Ly-70, IMD16, CD134, ACT-135, TXGP1L OX40/TNFRSF4 Protein, Mouse, Recombinant (His & Avi), Biotinylated
RHC-CD-2327
24.2 kDa (predicted). Due to glycosylation, the pr
TXGP1L, Txgp1, TNFRSF4, OX40L receptor, OX40, Ly-70, CD134, ACT-135 OX40L/TNFSF4 Protein, Mouse, Recombinant (His)
RHC-CD-1792
18.1 kDa (predicted)
Txgp1l, TXGP1, tumor necrosis factor (ligand) superfamily, member 4, OX-40L, Ox40l, gp34, CD134L, Ath-1, Ath1 OX40L/TNFSF4 Protein, Mouse, Recombinant (mFc)
RHC-CD-2044
42.7 kDa (predicted)
Txgp1l, TXGP1, tumor necrosis factor (ligand) superfamily, member 4, OX-40L, Ox40l, gp34, CD134L, Ath-1, Ath1 OX40L/TNFSF4 Protein, Mouse, Recombinant (rFc)
RHC-CD-1886
44.4 kDa (predicted)
Txgp1l, TXGP1, tumor necrosis factor (ligand) superfamily, member 4, OX-40L, Ox40l, gp34, CD134L, Ath-1, Ath1 OX40L/TNFSF4 Trimer Protein, Human, Recombinant (His & Flag)
RHC-CD-2072
49.7 kDa (predicted). Due to glycosylation, the pr
TNFSF4, OX4OL, OX-40L, OX40L, OX40 Ligand, Glycoprotein Gp34, CD252, CD134L, CD134 ligand, TXGP1 OXACILLIN FOR PEAK IDENTIFICATION
CAS:7240-38-2
Trade Name: sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-az
Formula: C19H18N3O5S.Na.H2O
APS7240382B
441.43
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, monosodium salt, monohydrate, [2S-(2alpha,5alpha,6beta)]- (9CI),Oxacillin Sodium Monohydrate, 4-Thia-1-azabicyclo[ OXACILLIN PENILLIC ACID DISODIUM SALT, 80% (MIXTURE OF DIASTEREOMERS)
Trade Name: disodium;2,2-dimethyl-5-(5-methyl-3-phenyl-isoxazol-4-yl)-7,7a-dihydro-3H-imidazo[5,1-b]thiazole-3,7
Formula: C19H17N3O5S.2Na
APS002695
445.40
2,3,7,7a-Tetrahydro-2,2-dimethyl-5-(5-methyl-3-phenyl-4-isoxazolyl)-Imidazo[5,1-b]thiazole-3,7-dicarboxylic Acid Disodium Salt Oxacillin sodium 100 -¦g/mL in Acetonitrile
CAS:7240-38-2
Trade Name: sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-az
Formula: C19H18N3O5S.Na.H2O
APS7240382A
441.43
Oxacillin sodium hydrate, Sodium oxacillin monohydrate, 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, monosodium salt, monohydrate, [2S-(2alpha,5alpha,6beta)]- OXACILLIN SODIUM MONOHYDRATE
CAS:7240-38-2
Trade Name: sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-az
Formula: C19H18N3O5S.Na.H2O
APS7240382
441.43
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, monosodium salt, monohydrate, [2S-(2alpha,5alpha,6beta)]- (9CI),Oxacillin Sodium Monohydrate, Oxacillin sodium hyd Oxacyclodotriaconta-3,5,7,9,11,29-hexaen-2-one,14,16,18,20,22,24,26,28-octahydroxy-31-methyl-32-(1-methylethyl)-,(3E,5E,7E,9E,11E,14S,16S,18S,20S,22R,24S,26RCAS:154396-73-3
Trade Name: 32-ethyl-14,16,18,20,22,24,26,28-octahydroxy-15,31-dimethyl-1-oxacyclodotriaconta-3,5,7,9,11,29-hexa
Formula: C35H56O10
ACM154396733
636.8131
RK-397;14-demethyl-mycoticin;14-demethylmycoticina;RK 7 OXACYCLOHEXADEC-13-ENE-2,6-DIONE,4,8-DIHYDROXY-5,5,7,9-TETRAMETHYL-16-(1E)-1-METHYL-2-(2-METHYL-4-THIAZOLYL)ETHENYL-,(4S,7R,8S,9S,13Z,16S)-
CAS:186692-73-9
Formula: C26H39NO5S
ACM186692739
0
Oxacyclohexadec-13-ene-2,6-dione, 4,8-dihydroxy-5,5,7,9-tetramethyl-16-(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl-, (4S,7R,8S,9S,13Z,16S)-;(4S,7R,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl) OXADIAZON-D7
Formula: C15H11D7Cl2N2O3
ACMA00059966
352.26
3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one-d7; 2-tert-Butyl-4-(2,4-dichloro-5-isopropoxyphenyl)-1,3,4-oxadiazolin-5-one-d7; 2-tert-Butyl-4-(2,4-dichloro-5-isopropoxyphenyl)-5-oxo-1,3,4-oxadiazo OXADIAZON-D9
Formula: C15H9D9Cl2N2O3
ACMA00059967
354.28
3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one-d9; 2-tert-Butyl-4-(2,4-dichloro-5-isopropoxyphenyl)-1,3,4-oxadiazolin-5-one-d9; 2-tert-Butyl-4-(2,4-dichloro-5-isopropoxyphenyl)-5-oxo-1,3,4-oxadiazo OXALIC ACID
CAS:144-62-7
Trade Name: oxalic acid
Formula: C2H2O4
APS144627
90.03
NSC 132055, NSC 151956, Ethanedioic acid, NSC 62774,Oxalic Acid, Oxalic acid, DeerClean, Ultraplast Activate S 52, Aktisal, Aquisal, NSC 76990 Oxalic acid 10 -¦g/mL in Acetonitrile
CAS:144-62-7
Trade Name: oxalic acid
Formula: C2H2O4
APS144627A
90.03
Ultraplast Activate S 52, Oxalic acid, Aquisal, DeerClean, Ethanedioic acid, Aktisal,Oxalic Acid, NSC 132055, NSC 151956, NSC 76990, NSC 62774 OXALIC ACID MONOETHYL ESTER
CAS:617-37-8
Trade Name: 2-ethoxy-2-oxoacetic acid
Formula: C4H6O4
ACM617378
118.09
2-ethoxy-2-oxoacetic acid, Ethoxy(oxo)acetic acid, 617-37-8, Monoethyl oxalate, AmbkkkkK287, Ethyl hydrogen oxalate, AC1L2MGY, AC1Q5RMR, ACMC-1B1OW, oxalic acid 1-ethyl ester, Oxalic acid monoethyl ester, MolPort-001-779-639, AR-1I7819, AKO OXALIMIDOHYDRAZIDE
CAS:3457-37-2
Trade Name: 1-N,2-N-diaminoethanediimidamide
Formula: C2H8N6
ACM3457372
116.125120 [g/mol]
Oxalamidrazone, Oxalimidohydrazide, Oxalic acid bisamidrazone, Diimidooxalic acid dihydrazide, Diimidooxalic acid hydrazide, Oxalimidic acid, dihydrazide, Diimidoxalic acid dihydrazide, (1Z,2Z)-ethanedihydrazonamide, Ethanediimidic acid, di OXALIPLATIN IMPURITY B
CAS:1613271-93-4
Formula: 2C7H7O3S.C6H18N2O2Pt
APS1613271934
687.68
(SP-4-2)-Diaqua[(1R,2R)-cyclo-hexane-1,2-diamine-+¦N,+¦N']platinum ditosylate,Platinum(2+), diaqua[(1R,2R)-1,2-cyclohexanediamine-+¦N1,+¦N2]-, (SP-4-2)-, 4-methylbenzenesulfonate (1:2), Diaquodiaminocyclohexaneplatinum ditosylate OXALIPLATIN IMPURITY C
CAS:111321-67-6
Formula: C8H16N2O6Pt
APS111321676A
431.30
Oxaliplatin Related Compound C (USP), 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-, Platinum, (1,2-cyclohexanediamine-N,N')[ethanedioato(2-)-O,O']dihydroxy-, [OC-6-33-(1R-trans)]- (9CI), Oxaliplatin Imp. C (EP),Platinum, [(1R,2R)-1 OXALIPLATIN IMPURITY D
CAS:61758-77-8
Formula: C8H14N2O4Pt
APS61758778A
397.29
Platinum, (1,2-cyclohexanediamine-kappaN,kappaN')[ethanedioato(2-)-kappaO1,kappaO2]-, [SP-4-2-[1S-(trans)]]-, 1,2-Cyclohexanediamine, platinum complex, (1S-trans)-, NSC 266042, (SP-4-2)-[(1S,2S)-Cyclohexane-1,2-diamine-kappaN,kappaN'][ethan |
